| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1016224481 |
| P356 | DOI | 10.1038/SJ.TPJ.6500156 |
| P698 | PubMed publication ID | 12746735 |
| P5875 | ResearchGate publication ID | 10759706 |
| P50 | author | Marion Leboyer | Q28444907 |
| Julie D. Henry | Q44218309 | ||
| Frank Bellivier | Q56479996 | ||
| P2093 | author name string | Fournier G | |
| Malafosse A | |||
| Ferrero F | |||
| Aubry JM | |||
| Laplanche JL | |||
| Baud P | |||
| Buresi C | |||
| Boucherie M | |||
| Rousseva A | |||
| van den Bulke D | |||
| P2860 | cites work | Rapid-cycling bipolar disorder. An overview of research and clinical experience | Q33768223 |
| Have some guidelines for the treatment of acute bipolar depression gone too far in the restriction of antidepressants? | Q33942947 | ||
| Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative | Q34324588 | ||
| Association between violent suicidal behavior and the low activity allele of the serotonin transporter gene | Q43590763 | ||
| The role of serotonin transporter protein gene in antidepressant-induced mania in bipolar disorder: preliminary findings | Q43626488 | ||
| Influence of tryptophan hydroxylase and serotonin transporter genes on fluvoxamine antidepressant activity. | Q43722419 | ||
| Dose-response relationship of selective serotonin reuptake inhibitors treatment-emergent hypomania in depressive disorders | Q43725413 | ||
| Role of serotonin transporter promoter repeat length polymorphism (5-HTTLPR) in seasonality and seasonal affective disorder | Q48475583 | ||
| Possible association between serotonin transporter gene polymorphism and violent suicidal behavior in mood disorders | Q57698088 | ||
| Serotonin transporter gene polymorphisms in patients with unipolar or bipolar depression | Q57698109 | ||
| Efficacy of Paroxetine in Depression Is Influenced by a Functional Polymorphism Within the Promoter of the Serotonin Transporter Gene | Q58451550 | ||
| Monte Carlo tests for associations between disease and alleles at highly polymorphic loci | Q60627367 | ||
| Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine | Q60631126 | ||
| Practice guideline for the treatment of patients with bipolar disorder. American Psychiatric Association | Q72850842 | ||
| Serotonin transporter gene polymorphism and antidepressant response | Q73467393 | ||
| The serotonin transporter in the midbrain of suicide victims with major depression | Q73914661 | ||
| P433 | issue | 2 | |
| P921 | main subject | serotonin | Q167934 |
| P304 | page(s) | 101-104 | |
| P577 | publication date | 2003-01-01 | |
| P1433 | published in | The Pharmacogenomics Journal | Q10534704 |
| P1476 | title | Antidepressant-induced mania, rapid cycling and the serotonin transporter gene polymorphism | |
| P478 | volume | 3 |
| Q33658525 | A neurobiological hypothesis of treatment-resistant depression - mechanisms for selective serotonin reuptake inhibitor non-efficacy |
| Q36934843 | A preliminary study of sustained-release bupropion for smoking cessation in bipolar disorder |
| Q47759280 | A re-examination of antidepressant treatment-emergent mania in bipolar disorders: evidence of gender differences |
| Q36248038 | Antidepressant-induced manic conversion: a developmentally informed synthesis of the literature |
| Q36624146 | Antidepressants and suicidal behavior in bipolar disorder |
| Q34316695 | Association of the 5-HTT gene-linked promoter region (5-HTTLPR) polymorphism with psychiatric disorders: review of psychopathology and pharmacotherapy |
| Q35089923 | Avoiding drug-induced switching in patients with bipolar depression |
| Q36286401 | Benefits and limitations of antidepressants and traditional mood stabilizers for treatment of bipolar depression |
| Q22241210 | Bipolar Disorder: An Update |
| Q39455953 | Bipolar affective disorder and Parkinson's disease |
| Q33697785 | CRY2 is associated with rapid cycling in bipolar disorder patients |
| Q37255370 | Clinical implications of genetic variation in the serotonin transporter promoter region: a review |
| Q36204951 | Course of illness following prospectively observed mania or hypomania in individuals presenting with unipolar depression |
| Q38297855 | Current landscape, unmet needs, and future directions for treatment of bipolar depression |
| Q35012645 | Fluoxetine-induced alterations in human platelet serotonin transporter expression: serotonin transporter polymorphism effects |
| Q45009936 | Fluoxetine-induced mania in an Asian patient |
| Q44973734 | Genetic features of antidepressant induced mania and hypo-mania in bipolar disorder |
| Q30485725 | How the serotonin story is being rewritten by new gene-based discoveries principally related to SLC6A4, the serotonin transporter gene, which functions to influence all cellular serotonin systems. |
| Q91360439 | Long-term prospective mood self-rating and antidepressant treatment |
| Q37400532 | Management of obsessive-compulsive disorder comorbid with bipolar disorder |
| Q34404924 | P2RX7: expression responds to sleep deprivation and associates with rapid cycling in bipolar disorder type 1. |
| Q36677640 | Panic comorbidity with bipolar disorder: what is the manic-panic connection? |
| Q36460262 | Pharmacogenetics in mood disorder |
| Q37989490 | Pharmacogenetics of antidepressant drugs: current clinical practice and future directions |
| Q34155796 | Pharmacogenetics of antidepressant response |
| Q36095772 | Population-based and family-based studies on the serotonin transporter gene polymorphisms and bipolar disorder: a systematic review and meta-analysis. |
| Q22242605 | Rapid cycling bipolar disorder - diagnostic concepts |
| Q33679424 | Role of variation in the serotonin transporter protein gene (SLC6A4) in trait disturbances in the ventral anterior cingulate in bipolar disorder |
| Q39400564 | Serotonin Transporter Gene Polymorphisms and Selective Serotonin Reuptake Inhibitor Tolerability: Review of Pharmacogenetic Evidence |
| Q35871016 | Structure-function associations in hippocampus in bipolar disorder |
| Q46828984 | Temperament and character in mood disorders: influence of DRD4, SERTPR, TPH and MAO-A polymorphisms |
| Q22241114 | The Neurobiology of the Switch Process in Bipolar Disorder |
| Q37805730 | The pharmacogenetics of antidepressant‐induced mania: a systematic review and meta‐analysis |
| Q37035245 | The serotonin transporter gene and effectiveness of SSRIs. |
| Q34203722 | Tryptophan-hydroxylase 2 haplotype association with borderline personality disorder and aggression in a sample of patients with personality disorders and healthy controls |
Search more.